Clinical Trial Update: Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant chemoradiotherapy plus a PD-1 inhibitor and thymalfasin for pMMR/MSS locally advanced mid-low rectal cancer. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 inhibitor
• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING